Ron Suskind is a Pulitzer Prize-winning journalist and best-selling author, lecturer at Harvard Law School, and founder and chief executive officer of The Affinity Project/Sidekicks, a developer of augmentative technologies for ‘at need’ populations, starting with autism.
Ron Suskind
Founder
The Affinity Project/Sidekicks
From this contributor
Animated sidekick connects parents to children with autism
In a new type of therapy for autism, parents talk or type into their phone or computer, and their words emerge in the voice of an animated character.
Animated sidekick connects parents to children with autism
By
Ron Suskind
21 February 2017 | 9 min read
Explore more from The Transmitter
Many students want to learn to use artificial intelligence responsibly. But their professors are struggling to meet that need.
Effectively teaching students how to employ AI in their writing assignments requires clear guidelines—and detailed, case-specific examples.
Many students want to learn to use artificial intelligence responsibly. But their professors are struggling to meet that need.
Effectively teaching students how to employ AI in their writing assignments requires clear guidelines—and detailed, case-specific examples.
By
Tim Requarth
23 June 2025 | 8 min listen
The big idea with Diego Bohórquez
His theories around the neuropod have challenged the boundaries of classic ideas regarding gut-brain communication.
The big idea with Diego Bohórquez
His theories around the neuropod have challenged the boundaries of classic ideas regarding gut-brain communication.
By
Sydney Wyatt
20 June 2025 | 14 min listen
Genetic background steers PTEN syndrome traits
People with the syndrome, caused by variants in the gene PTEN, often have autism or cancer, or both, but it depends on the genetic diversity encoded in the components of distinct cell signaling pathways, according to a new study.
Genetic background steers PTEN syndrome traits
People with the syndrome, caused by variants in the gene PTEN, often have autism or cancer, or both, but it depends on the genetic diversity encoded in the components of distinct cell signaling pathways, according to a new study.
By
Holly Barker
19 June 2025 | 5 min listen